Noninvasive first-trimester screening for fetal aneuploidy

Obstetrical and Gynecological Survey

Volumn 52, Issue 2, 1997, Pages 123-129

  Sherer, David M ^a   Bombard, Allan T ^a   Kellner, Leonard H ^a   Divon, Michael Y ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CHORIONIC GONADOTROPIN BETA SUBUNIT; INHIBIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN;

ANEUPLOIDY; CHROMOSOME ABERRATION; FETUS; FETUS CELL; FETUS DEVELOPMENT; FETUS DISEASE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL AGE; MATERNAL SERUM; PRENATAL DIAGNOSIS; REVIEW; SCREENING TEST; TRISOMY 21;

ANEUPLOIDY; BIOLOGICAL MARKERS; FEASIBILITY STUDIES; FEMALE; FETAL DISEASES; GENETIC SCREENING; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 0031059201     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199702000-00021     Document Type: Review

References (89)

1. Hsu LYF. Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Milunsky A (ed). Genetic disorders of the fetus: Diagnosis, prevention and treatment, 3rd ed. Baltimore: Johns Hopkins University Press, 1992, pp 155-210.
2. Benacerraf BR, Barss VA, Laboda LA. A sonographic sign for the detection in the second trimester of the fetus with Down syndrome. Am J Obstet Gynecol 1985;151:1078-1079.
3. Benacerraf BR. The second trimester fetus with Down syndrome; detection using sonographic features. Ultrasound Obstet Gynecol 1996;7:147-155.
4. Benacerraf BR, Frigoletto FD. Soft tissue nuchal fold in the second trimester fetus: Standards for normal measurements compared to the fetus with Down syndrome. Am J Obstet Gynecol 1987;157:1146-1149.
5. Merkatz IR, Nitkowski HM, Macri JN et al. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-894.
6. Bogart HM, Pandian MR, Jones OW. Abnormal maternal serum human chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-630.
7. Bronshtein M, Rottem S, Yoffe N et al. First trimester and early second trimester diagnosis of nuchal cystic hygroma by transvaginal sonography: Diverse prognosis of the septated from the non-septated lesion. Am J Obstet Gynecol 1989;161:78-82.
8. Cullen MT, Gabrielli S, Green JJ et al. Diagnosis and significance of cystic hygroma in the first trimester. Prenat Diagn 1990;10:643-651.
9. Ville Y, Lalondrelle C, Doumerc S et al. First trimester diagnosis of nuchal anomalies: Significance and fetal outcome. Ultrasound Obstet Gynecol 1992;2:314-316.
10. Shulman LP, Emerson DS, Felker RE et al. High frequency of cytogenetic abnormalities in fetuses with cystic hygroma diagnosed in the first trimester. Obstet Gynecol 1992;80:80-2.
11. Nicholaides KH, Azar G, Bryne D et al. Fetal nuchal translucency; ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992;304:867-869.
12. Van Zalen-Sprock MM, Van Vugt JMG et al. First trimester diagnosis of cystic hygroma - Course and outcome. Am J Obstet Gynecol 1992;167:94-98.
13. Savoldelli G, Binkert F, Achermann J et al. Ultrasound screening for chromosomal abnormalities in the first trimester of pregnancy. Prenat Diagn 1993;13:513-518.
14. Johnson MK, Johnson A, Holzgreve W et al. First trimester simple hygroma: Cause and outcome. Am J Obstet Gynecol 1993;168:156-161.
15. Nadel A, Bromley B, Benacerraf BR. Nuchal thickening or cystic hygromas in first-and early second-trimester fetuses: Prognosis and outcome. Obstet Gynecol 1993;82:43-48.
16. Pandya PP, Brizot ML, Snijders RJM. Fetal nuchal translucency thickness and risk for trisomies. Obstet Gynecol 1994; 84:420-423.
17. Nicolaides KH, Brizot ML, Snijders RJM. Fetal nuchal translucency; ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994;101:782-786.
18. Comas C, Matinez JM, Ojuel J et al. First trimester nuchal edema as a marker of aneuploidy. Ultrasound Obstet Gynecol 1995;5:26-29.
19. Brambati B, Cislaghi C, Tului L et al. First trimester Down syndrome screening using nuchal translucency: A prospective study in patients undergoing chorionic villus sampling. Ultrasound Obstet Gynecol 1995;5:9-14.
20. Pandya PP, Kondylios A, Hilbert L et al. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995;5:15-19.
21. Snijders RJM, Johnson S, Sebire NJ et al. First trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 1996;7:216-226.
22. Mahieu-Caputo D, Dommergues M, Morichon-Delvallez N et al. First trimester translucency: Aneuploidy, sonographic findings, and maternal age. Fetal Diagn Ther 1996;11:199-204.
23. Pandya PP, Snijders RJM, Johnson SP et al. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995;102:957-962.
24. Pandya PP, Hilbert F, Snijders RJM et al. Nuchal translucency thickness and crown-rump length in twin pregnancies with chromosomally abnormal fetuses. J Ultrasound Med 1995;14: 565-568.
25. Snijders RJM, Sebire NJ, Souka A et al. Maternal age and gestational age specific risk for chromosomal defects. Fetal Diagn Ther 1995;10:356-367.
26. Hyett JA, Sebire NJ, Snijders RJM et al. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 1996;7:101-103.
27. Hyett JA, Mosoco G, Nicolaides KH. First trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21. Am J Obstet Gynecol 1995;172:1411-1413.
28. Hyett JA, Mosoco G, Nicolaides KH. Increased nuchal translucency in trisomy 21 fetuses; relation to narrowing of the aortic isthmus. Hum Reprod 1995;10:3049-3051.
29. Pandya PP, Snijders RJM, Johnson SP et al. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 1995;5:381-383.
30. Hyett JA, Noble PL, Snijders RJM et al. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10 to 14 weeks of gestation. Ultrasound Obstet Gynecol 1996;7:239-244.
31. Brizot ML, Snijders RJM, Bersinger NA et al. Maternal serum pregnancy associated placental protein A (PAPP-A) and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy. Obstet Gynecol 1994;84:918-922.
32. Brizot ML, Snijders RJM, Butler J et al. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy. Br J Obstet Gynaecol 1995;102:127-132.
33. Noble PL, Abraham HD, Snijders RJM et al. Screening for fetal trisomy 21 in the first trimester of pregnancy: Maternal serum free β-hCG and fetal nuchal translucency thickness. Ultrasound Obstet Gynecol 1995;6:390-395.
34. Pandya PP, Goldberg H, Walton B et al. The implementation of first trimester scanning at 10 to 13 weeks gestation and the measurement of fetal nuchal translucency thickness in two maternity units. Ultrasound Obstet Gynecol 1995;5:20-25.
35. Roberts LJ, Bewley S, Mackinson AM et al. First trimester fetal nuchal translucency: Problems with screening the general population. Br J 1995;102:381-385.
36. Bewley S, Roberts LJ, Mackinson AM et al. First trimester fetal nuchal translucency: Problems with screening the general population 2. Br J Obstet Gynaecol 1995;102:386-388.
37. Pandya PP, Altman DG, Brizot ML et al. Repeatability of measurement of fetal nuchal thickness. Ultrasound Obstet Gynecol 1995;5:334-337.
38. Lynch L, Berkowitz RL. First trimester growth delay in trisomy 18. Am J Perinatol 1989;6:237-239.
39. Kuhn P, Brizot ML, Pandya PP et al. Crown-rump length in chromosomally abnormal fetuses at 10 to 13 weeks' gestation. Am J Obstet Gynecol 1995;172:32-35.
40. Drugan A, Johnson MP, Isada NB et al. The smaller than expected first trimester fetus is at increased risk for chromosome anomalies. Am J Obstet Gynecol 1992;167:1525-1528.
41. Wald NJ, Smith D, Kennard A et al. Biparietal diameter and crown-rump length in fetuses with Down's syndrome: Implications for antenatal serum screening for Down's syndrome. Br J Obstet Gynaecol 1993;100:430-435.
42. Leelapatana P, Garrett WJ, Warren PS. Early growth retardation in the first trimester: Is it characteristic of the chromosomally abnormal fetus. Aust NZ J Obstet Gynaecol 1992;32: 95-97.
43. Wasserman SA, Bofinger MK, Saldana LR. Ultrasound and genetic features of a term triploid pregnancy. Am J Perinatol 1991;8:398-401.
44. Benacerraf BR. Intrauterine growth retardation in the first trimester associated with triploidy. J Ultrasound Med 1988;7: 153-154.
45. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-630.
46. Canick JA, Knight GJ, Palomaki GE et al. Low second trimester maternal serum unconjugated estriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 1988;95:330-333.
47. Wald NJ, Cuckle HS, Densem JW et al. Maternal serum screening for Down syndrome in early pregnancy. Br Med J 1988;297:883-887.
48. Wald NJ, Kennard A, Hackshaw AK. First trimester screening for Down's syndrome. Prenat Diagn 1995;15:1227-1240
49. Brambati B, Macintosh MCM, Teisner B et al. Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyoptype. Br. J Obstet Gynaecol 1993;100:324-326.
50. Brock DJH, Barron L, Halloway S et al. First-trimester maternal serum biochemical indicators in Down syndrome. Prenat Diagn 1990;10:245-251.
51. Johnson A, Cowchock FS, Darby M et al. First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies Prenat Diagn 1991;11:443-450.
52. Nebiolo L, Ozturk M, Brambati B et al. First-trimester maternal serum alpha-fetoprotein and human chorionic gonadotropin screening for chromosome defects. Prenat Diagn 1990;10: 575-581.
53. Spencer K, Aitken DA, Crossley JA et al. First-trimester biochemical screening for trisomy 21: The role of free beta-hCG, alpha fetoprotein and pregnancy-associated plasma protein A. Ann Clin Biochem 1994;31:447-454.
54. Crandall BF, Golbus M, Goldberg JD et al. First trimester maternal serum unconjugated estriol and alpha-fetoprotein in fetal Down's syndrome. Prenat Diagn 1991;11:377-380.
55. Macintosh MCM, Brambati B, Chard T et al. First trimester maternal serum Schwangerschafts protein 1 (SP1) in pregnancies associated with chromosomal anomalies. Prenat Diagn 1993;13:563-8.
56. Krantz DA, Larsen JW, Buchanan PD et al. First trimester Down syndrome screening: Free β-human chorionic gonadotropin and pregnancy-associated plasma protein A. Am J Obstet Gynecol 1996;174:612-6.
57. Cuckle HS, Iles RK, Chard T. Urinary β-core human chorionic gonadotropin; a new approach to Down's syndrome screening. Prenat Diagn 1994;14:953-8.
58. Brambati B, Tului L, Bonacchi I et al. Serum PAPP-A and free β-hCG are first trimester markers for Down syndrome. Prenat Diagn 1994;14:1043-7.
59. Van Lith JMM. First trimester maternal serum alpha-fetoprotein as a marker for fetal chromosomal disorders. Prenat Diagn 1994;14:963-971.
60. Berry E, Aitken DA, Crossley JA et al. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotropin in first trimester: implications for Down's syndrome screening. Prenat Diagn 1995;15:555-565.
61. Macintosh MCM, Iles R, Teisner B et al. Maternal serum human chorionic gonadotropin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8 to 14 weeks. Prenat Diagn 1994;14:203-208.
62. Wallace EM, Grant VE, Swanston IA et al. Evaluation of maternal dimeric inhibin A as a first trimester marker of Down's syndrome. Prenat Diagn 1995;15:359-362.
63. Aitken DA, Wallace EM, Crossley JA et al. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N Engl J Med 1996;334:1231-1236.
64. Cuckle HS, Canick JA, Kellner LH et al. Urinary β-core hCG screening in the first trimester. Prenat Diagn 1996;16:1057-1059.
65. Simpson JL, Elias S. Isolating fetal cells from maternal blood Advances in prenatal diagnosis through molecular technology. J Am Med Assoc 1993;270:2357-2361.
66. Geifman-Holtzman O, Blatman RN, Bianchi DW. Prenatal genetic diagnosis by isolation and analysis of fetal cells circulating in maternal blood. Semin Perinatol 1994;18:366-375.
67. Adinolfi M. Non-or minimally invasive prenatal diagnostic tests on maternal blood samples or transcervical cells. Prenat Diagn 1995;15:889-896.
68. Simpson JL, Elias S. Isolating fetal cells in maternal circulation for prenatal diagnosis. Prenat Diagn 1994;14:1229-1242.
69. Adinolfi M. Breaking the blood barrier. Nature Genet 1992;1: 316-318.
70. Adinolfi M. On a noninvasive approach to prenatal diagnosis based on the detection of fetal nucleated cells in maternal blood samples. Prenat Diagn 1991;11:799-804.
71. Zheng YL, Carter NP, Price CM et al. Prenatal diagnosis from maternal blood: Simultaneous immunophenotyping and FISH of fetal nucleated erythrocytes isolated by negative magnetic cell sorting. J Med Genet 1993;30:1051-1056.
72. Bianchi DW, Zickwolf GK, Yih MC et al. Erythroid-specific antibodies enhance detection of fetal nucleated erythrocytes in maternal blood. Prenat Diagn 1993;13:293-300.
73. Price J, Elias S, Wachtel SS et al. Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry. Am J Obstet Gynecol 1991;165:1731-1737.
74. Ward BE, Gersen SL, Carelli MP et al. Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescent in situ hybridization: Clinical experience with 4500 specimens. Am J Hum Genet 1993;52:854-865.
75. Büsch J, Huber P, Pflüger E et al. Enrichment of fetal cells from maternal blood by high gradient magnetic cell sorting (double MACS) for PCR-based genetic analysis. Prenat Diagn 1994;14:1129-1140.
76. Bianchi DW, Shuber AP, DeMaria MA et al. Fetal cells in maternal blood: Determination of purity and yield by quantitative polymerase chain reaction. Am J Obstet Gynecol 1994; 171:922-926.
77. Adkison LR, Andrews RH, Vowell NL et al. Improved detection of fetal cells from maternal blood with polymerase chain reaction. Am J Obstet Gynecol 1994;170:952-955.
78. Elias S, Price J, Dockter M et al. First trimester prenatal diagnosis of trisomy 21 in fetal cells from maternal blood. Lancet 1992;340:1033.
79. Bianchi DW, Mahr A, Zickwolf GK et al. Detection of fetal cells with 47,XY +21 karyotype in maternal peripheral blood. Hum Genet 1992;90:368-370.
80. Gänshirt-Ahlert DR, Borjesson-Stoll M, Burschyk A et al. Detection of fetal trisomies 21 and 18 from maternal blood using triple gradient and magnetic cell sorting. Am J Reprod Immunol 1993;30:194-201.
81. Simpson JL, Lewis DE, Bischoff FZ et al. Isolating fetal nucleated red blood cells from the maternal blood: The Baylor experience. Prenat Diagn 1995;15:907-912.
82. Shettles LB. Use of the Y chromosome in prenatal sex determination. Lancet 1971;230:52.
83. Griffith-Jones MD, Miller D, Lilford RJ et al. Detection of fetal DNA in transcervical swabs from the first trimester of pregnancies by gene amplification: A new route to prenatal diagnosis? Br J Obstet Gynaecol 1992;99:508-511.
84. Rodeck C, Tutschek B, Sherlock J et al. Methods for the transcervical collection of fetal cells during the first trimester of pregnancy. Prenat Diagn 1995;15:933-942.
85. Adinolfi M, Sherlock J, Tutshceck B et al.Detection of fetal cells in transcervical samples and prenatal diagnosis of chromosomal abnormalities. Prenat Diagn 1995;15:943-989.
86. Kingdom J, Sherlock J, Roedeck C et al. Detection of trophoblast cells in transcervical samples collected by lavage or cytobrush. Obstet Gynecol 1995;86:283-288.
87. Tutshcek Sherlock J, Halder A et al. Isolation of fetal cells from transcervical samples by micromanipulation: Molecular confirmation of their fetal origin and diagnosis of fetal aneuploidy. Prenat Diagn 1995;15:951-960.
88. Adinolfi M, Davies A, Sharif S et al. Detection of trisomy 18 and Y-derived sequences in fetal nucleated cells obtained by transcervical flushing. Lancet 1993;342:403-404.
89. Adinolfi M, Sherlock J, Kemp T et al. Prenatal detection of fetal RhD DNA sequences in transcervical samples. Lancet 1995;345:318-319.